Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Cystic Fibrosis
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Cystic Fibrosis
    TopAbstracts in Cystic Fibrosis 06/30/2008 - (DGNews)
    TopAbstracts in Cystic Fibrosis 06/02/2008 - (DGNews)
    TopAbstracts in Cystic Fibrosis 05/05/2008 - (DGNews)
    TopAbstracts in Cystic Fibrosis 04/07/2008 - (DGNews)
    TopAbstracts in Cystic Fibrosis 03/10/2008 - (DGNews)

    News archive

     Recent webcasts/CME - Cystic Fibrosis
      Diagnosis of Cystic Fibrosis
      Aggressive Treatment Strategies in the Fight Against Cystic Fibrosis
      Disease Managment Lessons of Cystic Fibrosis: Paradigms From an Orphan

      Webcasts/CME archive

       Recent cases - Cystic Fibrosis
        An Atypical Presentation of Cystic Fibrosis: A Case Report
        Cystic Fibrosis Presenting as Recurrent Pancreatitis in a Young Child with a Normal Sweat Test and Pancreas Divisum: A Case Report
        Extracorporeal Membrane Oxygenator as a Bridge to Successful Surgical Repair of Bronchopleural Fistula Following Bilateral Sequential Lung Transplantation; A Case Report and Review of Literature
        Cystic Fibrosis and Renal Disease: A Case Report
        Inhaled Tobramycin Solution-Associated Recurrent Eosinophilia and Severe Persistent Bronchospasm in a Patient with Cystic Fibrosis: A Case Report

        Cases archive
          




        my personal edition > cystic fibrosis > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Testing Allows Early Pseudomonas aeruginosa Detection In Cystic Fibrosis

        A DGReview of :"Respiratory Infections With Pseudomonas aeruginosa in Children With Cystic Fibrosis Early Detection by Serology and Assessment of Risk Factors"
        Journal of the American Medical Association (JAMA)

        06/12/2002
        By Elda Hauschildt


        Neonatal screening for three antibodies allows early detection of the bacteria that causes Pseudomonas aeruginosa pulmonary infection in children with cystic fibrosis (CF).

        Testing for immunoglobins IgG, IgA and IgM allows P aeruginosa detection six to 12 months before the organism is identified in cultures.

        Researchers from the University of Wisconsin in Madison and the Medical College of Wisconsin in Milwaukee, United States, say such testing could facilitate diagnosis and treatment of children with CF: "Early diagnosis through neonatal screening provides an opportunity for a transformation in treatment strategy.

        "Instead of hospitalisations and medical interventions for sick patients who experience delayed diagnosis, screening allows pre-symptomatic identification of most patients with CF and the potential for prospective evaluation and preventive care."

        They explain that the CF lung is free of pathology at birth. "Early diagnosis coupled with careful follow-up of the respiratory symptoms (especially cough), infection status and chest radiographs could provide better outcomes."

        Researchers also recommend that longitudinal P aeruginosa serology become part of the children's respiratory care follow-up, especially the use of exotoxin A titres.

        They evaluated the longitudinal relationship between the production of antibody response against P aeruginosa and clinical factors associated with infections in 68 CF patients who had been diagnosed early.

        Serum samples and oropharyngeal cultures were obtained from participants at six-month intervals from April 1995 to April 2000 or for up to 180 months, depending on the enrolment date. Participants had been diagnosed through the Wisconsin CF Neonatal Screening Project.

        The median time to an antibody titre of at least 1:256 was 17.8 months for cell lysates, 24.2 months for exotoxin A and 70.9 months for elastase.

        The rise of anti-cell lysates titres to 1:256 or more occurred a mean of 11.9 months before the isolation of P aeruginosa for all cultures. For anti-exotoxin A titres, the mean time was 5.6 months.

        "Treatment with long-term, non-Pseudomonas oral antibiotics and integration of CF infants with older, chronically infected patients were associated with a significantly increased risk of P aeruginosa pulmonary infection," the researchers add.
        JAMA, 2002; 287: 2958-2967. "Respiratory Infections With Pseudomonas aeruginosa in Children With Cystic Fibrosis Early Detection by Serology and Assessment of Risk Factors"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send